Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Effects of Interruptions in HIV Therapy on Cellular Aging
EF 2018-19
Résumé
People living with HIV experience accelerated aging. HIV+ individuals die a decade earlier and develop age related diseases earlier than the general population. Such diseases include heart, liver, bone, kidney, and Alzheimer’s disease, as well as some cancers. It is unclear if this is due to the HIV virus (which can cause chronic inflammation) or because of the side effects of the HIV drugs taken to treat the disease. Many HIV drugs are known to negatively affect mitochondrial DNA (mtDNA). The mitochondria are the power houses of the cell. As we grow older, we accumulate mutations in the mtDNA, which contains the instructions to build proteins needed for energy production. The more mutations we accumulate, the less energy we can produce, and the less able we are to maintain the health of our tissues. People living with HIV may age faster in part because they experience an accelerated accumulation of mtDNA mutations.
Previous studies suggested that uncontrolled HIV replication, as might occur during interruption(s) in HIV therapy, may accelerate aging and promote disease in people living with HIV. In fact, a clinical trial showed that taking scheduled breaks from HIV therapy increased the chance of heart, kidney, and liver disease, as well as death. These diseases are linked to mitochondrial dysfunction and/or older age. We hypothesize that periodically stopping and re-starting HIV therapy promotes the duplication of mutated copies of mtDNA and accelerates aging. I will measure mtDNA mutations among people living with HIV who either never stopped therapy or interrupted it many times, as well as HIV-negative controls. My study will inform health care providers and people living with HIV about the potential effects associated with therapy interruptions.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
406476
Name
Ziada Adam S
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Effects of Interruptions in HIV Therapy on Cellular Aging
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aging; Heteroplasmy; Hiv; Mitochondria; Mtdna; Somatic Mutations; Therapy Interruptions
Abstract
People living with HIV experience accelerated aging. HIV+ individuals die a decade earlier and develop age related diseases earlier than the general population. Such diseases include heart, liver, bone, kidney, and Alzheimer’s disease, as well as some cancers. It is unclear if this is due to the HIV virus (which can cause chronic inflammation) or because of the side effects of the HIV drugs taken to treat the disease. Many HIV drugs are known to negatively affect mitochondrial DNA (mtDNA). The mitochondria are the power houses of the cell. As we grow older, we accumulate mutations in the mtDNA, which contains the instructions to build proteins needed for energy production. The more mutations we accumulate, the less energy we can produce, and the less able we are to maintain the health of our tissues. People living with HIV may age faster in part because they experience an accelerated accumulation of mtDNA mutations.
Previous studies suggested that uncontrolled HIV replication, as might occur during interruption(s) in HIV therapy, may accelerate aging and promote disease in people living with HIV. In fact, a clinical trial showed that taking scheduled breaks from HIV therapy increased the chance of heart, kidney, and liver disease, as well as death. These diseases are linked to mitochondrial dysfunction and/or older age. We hypothesize that periodically stopping and re-starting HIV therapy promotes the duplication of mutated copies of mtDNA and accelerates aging. I will measure mtDNA mutations among people living with HIV who either never stopped therapy or interrupted it many times, as well as HIV-negative controls. My study will inform health care providers and people living with HIV about the potential effects associated with therapy interruptions.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ziada, Adam S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~